BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 20132572)

  • 1. [GHB withdrawal delirium].
    Stijnenbosch PJ; Zuketto C; Beijaert PJ; Maat A
    Ned Tijdschr Geneeskd; 2010; 154():A1086. PubMed ID: 20132572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gamma-hydroxybutyrate withdrawal syndrome.
    Dyer JE; Roth B; Hyma BA
    Ann Emerg Med; 2001 Feb; 37(2):147-53. PubMed ID: 11174231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Withdrawal syndrome after abuse of GHB (Gamma-Hydroxybutyrate) and its physiological precursors - its relevance for child and adolescent psychiatrists].
    Zepf FD; Holtmann M; Duketis E; Maier J; Radeloff D; Schirman S; Wagner A; Poustka F; Wöckel L
    Z Kinder Jugendpsychiatr Psychother; 2009 Sep; 37(5):413-20. PubMed ID: 19739059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Gamma-hydroxybutyric acid (GHB) dependence and the GHB withdrawal syndrome: diagnosis and treatment].
    van Noorden MS; Kamal R; de Jong CA; Vergouwen AC; Zitman FG
    Ned Tijdschr Geneeskd; 2010; 154():A1286. PubMed ID: 21040601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical management of gamma-hydroxybutyrate (GHB) withdrawal delirium with CIWA-Ar protocol.
    Liao PC; Chang HM; Chen LY
    J Formos Med Assoc; 2018 Dec; 117(12):1124-1127. PubMed ID: 29933901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gamma-hydroxybutyrate withdrawal syndrome: dangerous but not well-known.
    van Noorden MS; van Dongen LC; Zitman FG; Vergouwen TA
    Gen Hosp Psychiatry; 2009; 31(4):394-6. PubMed ID: 19555805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. gamma-Hydroxybutyrate withdrawal and chloral hydrate.
    Hutto B; Fairchild A; Bright R
    Am J Psychiatry; 2000 Oct; 157(10):1706. PubMed ID: 11007738
    [No Abstract]   [Full Text] [Related]  

  • 8. [Life threatening symptoms of withdrawal of gamma-hydroxybutyrate].
    Veerman SR; Dijkstra HN; Liefting-Kluft I
    Tijdschr Psychiatr; 2010; 52(6):411-6. PubMed ID: 20544599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical features and management of gamma-hydroxybutyrate (GHB) withdrawal: a review.
    McDonough M; Kennedy N; Glasper A; Bearn J
    Drug Alcohol Depend; 2004 Jul; 75(1):3-9. PubMed ID: 15225884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two cases of severe gamma-hydroxybutyrate withdrawal delirium on a psychiatric unit: recommendations for management.
    Rosenberg MH; Deerfield LJ; Baruch EM
    Am J Drug Alcohol Abuse; 2003 May; 29(2):487-96. PubMed ID: 12765217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pentobarbital for severe gamma-butyrolactone withdrawal.
    Sivilotti ML; Burns MJ; Aaron CK; Greenberg MJ
    Ann Emerg Med; 2001 Dec; 38(6):660-5. PubMed ID: 11719746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Baclofen and gamma-hydroxybutyrate withdrawal.
    LeTourneau JL; Hagg DS; Smith SM
    Neurocrit Care; 2008; 8(3):430-3. PubMed ID: 18266111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of gamma-hydroxybutyrate withdrawal].
    Strand NAW; Petersen TS; Nielsen LM; Boegevig S
    Ugeskr Laeger; 2017 Dec; 179(50):. PubMed ID: 29260701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Within-patient variability in clinical presentation of gamma-hydroxybutyrate withdrawal: a case report.
    Glasper A; McDonough M; Bearn J
    Eur Addict Res; 2005; 11(3):152-4. PubMed ID: 15990433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fatality due to gamma-hydroxybutyric acid (GHB) and heroin intoxication.
    Ferrara SD; Tedeschi L; Frison G; Rossi A
    J Forensic Sci; 1995 May; 40(3):501-4. PubMed ID: 7782758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GHB-induced delirium: a case report and review of the literature of gamma hydroxybutyric acid.
    Hernandez M; McDaniel CH; Costanza CD; Hernandez OJ
    Am J Drug Alcohol Abuse; 1998 Feb; 24(1):179-83. PubMed ID: 9513637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gamma-hydroxybutyrate detoxification by titration and tapering.
    de Jong CA; Kamal R; Dijkstra BA; de Haan HA
    Eur Addict Res; 2012; 18(1):40-5. PubMed ID: 22142784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seven days of gamma-hydroxybutyrate (GHB) use produces severe withdrawal.
    Perez E; Chu J; Bania T
    Ann Emerg Med; 2006 Aug; 48(2):219-20. PubMed ID: 16857475
    [No Abstract]   [Full Text] [Related]  

  • 19. A case series of pharmaceutical gamma-hydroxybutyrate in 3 patients with severe benzodiazepine-resistant gamma-hydroxybutyrate withdrawal in the hospital.
    van Noorden MS; Kamal RM; Dijkstra BA; Mauritz R; de Jong CA
    Psychosomatics; 2015; 56(4):404-9. PubMed ID: 25016356
    [No Abstract]   [Full Text] [Related]  

  • 20. [Withdrawal syndrome following chronic use of gamma-hydroxybutyric acid (GHB)].
    Moitroux A; Kestens C
    Rev Med Liege; 2023 Jul; 78(7-8):451-455. PubMed ID: 37560960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.